Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Early Hum Dev ; 89(12): 1049-54, 2013 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-24041816

RESUMO

OBJECTIVES: This study aims to assess the frequency of fetal bacterial infections in stillbirth (SB) and to evaluate the best samples for the diagnosis of infection-related SB. STUDY DESIGN: Consecutive cases of antepartum SB were enrolled. Vaginal and placental swabs, as well as heart blood cultures and surface swabs from the neonate, were collected. Histological examinations were performed by the same examiner. Immunohistochemistry for leukocyte common antigen was performed in the placenta and fetus. Each case was discussed in a multidisciplinary audit. RESULTS: One hundred and nine cases were enrolled. Fetal blood cultures were positive in 20/95 cases (21%). Significant histological findings in the placenta/cord and in at least one fetal organ were observed in 8 cases of them (4 Group B Streptococcus GBS, 2 Listeria monocytogenes, 1 Coagulase negative Staphylococcus, 1 Pseudomonas aeruginosa). Neither tissue damage nor inflammatory infiltrate was found in the 12 remnant cases. Funisitis while not histological chorioamnionitis was associated with microbiological findings. Positive findings in maternal/placental/fetal swabs occurred in 18-32% of cases with both negative fetal blood cultures and histopathological findings. With the exception of GBS, no other bacteria agent could be detected by any of the swabs. CONCLUSIONS: Eight cases (8.4%) fulfilled both microbiological and histology criteria allowing the diagnosis of SB-related fetal infection demonstrating that search for infections is essential in SB evaluation. Fetal blood culture, placenta swab for GBS and search for histological funisitis are mandatory actions within the SB work-up in order to guide pathology examination and reach clinical conclusions.


Assuntos
Infecções Bacterianas/epidemiologia , Corioamnionite/diagnóstico , Corioamnionite/epidemiologia , Corioamnionite/microbiologia , Morte Fetal/epidemiologia , Infecções Bacterianas/diagnóstico , Feminino , Sangue Fetal/microbiologia , Morte Fetal/microbiologia , Humanos , Imuno-Histoquímica , Itália , Antígenos Comuns de Leucócito/análise , Gravidez , Prevalência , Sensibilidade e Especificidade
2.
Minerva Ginecol ; 65(2): 215-21, 2013 Apr.
Artigo em Italiano | MEDLINE | ID: mdl-23598785

RESUMO

AIM: The aim of this study was to compare the effects of a dietary supplementation with oral probiotic, and the treatment with vaginal clindamycin in pregnant women with bacterial vaginosis. METHODS: Fourty pregnant women, with a diagnosis of bacterial vaginosis according to the Amsel criteria, were enrolled between the 10th and the 34th week of gestation. The patients were randomized in two groups. Patients in the group A were treated with probiotic orally (VSL3® Ferring), 2 tablets a day for 5 days, followed by 1 tablet daily for 10 days. Patients in group B were treated with vaginal clindamycin 100 mg daily for 15 days. After 5-10 days from the end of the treatment the patients returned for the follow-up. RESULTS: After treatment the vaginal discharge was completely absent in group A, and reduced in group B. The itching occurred only in 10% of patients in each of the two groups. The improvement of constipation occurs only in the group A (P=0.002). Vaginal swabs resulted negative in both groups in particular for Gardnerella V. CONCLUSION: The oral treatment with VSL#3® is effective in the treatment of VB in pregnant women as a topical treatment with clindamycin. In particular for the resolution of leukorrhea, itching and in particular in the bacterial vaginosis caused by Gardnerella V.


Assuntos
Complicações Infecciosas na Gravidez/dietoterapia , Probióticos/administração & dosagem , Vaginose Bacteriana/dietoterapia , Administração Oral , Adolescente , Adulto , Feminino , Humanos , Projetos Piloto , Gravidez , Adulto Jovem
3.
J Matern Fetal Neonatal Med ; 26(3): 306-12, 2013 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-22928540

RESUMO

OBJECTIVE: The use of herbal remedies has been documented both among various patient groups and in the general population to promote health. The aim of this systematic review is to analyze the benefits of herb use during pregnancy. METHODS: A systematic literature search covering the period from January 1990 to September 2010 was performed using various electronic databases. Randomized controlled clinical trials (RCTs) were included. Paper quality was evaluated using the Jadad scale. RESULTS: Of the 511 articles identified, 14 RCTs were eligible. Ginger was the most investigated remedy and was consistently reported to ameliorate nausea and vomiting during pregnancy better than placebo; its efficacy in doing so was noted to be equal to that of vitamin B6 and dimenhydrinate. A single trial also supported the use of Hypericum perforatum for wound healing. Cranberry, however, was not efficacious in the treatment of urinary tract infections; finally, raspberry leaf did not shorten the first stage of labor, and garlic did not prevent pre-eclampsia. CONCLUSIONS: Despite the widespread, popular use of herbal remedies during pregnancy, too few studies have been devoted to specific clinical investigations. With the exception of ginger, there is no data to support the use of any other herbal supplement during pregnancy.


Assuntos
Fitoterapia/estatística & dados numéricos , Preparações de Plantas/uso terapêutico , Complicações na Gravidez/tratamento farmacológico , Antieméticos/uso terapêutico , Feminino , Humanos , Náusea/tratamento farmacológico , Fitoterapia/métodos , Preparações de Plantas/efeitos adversos , Pré-Eclâmpsia/prevenção & controle , Gravidez , Complicações na Gravidez/epidemiologia , Ensaios Clínicos Controlados Aleatórios como Assunto , Vômito/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...